Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
Daniel J. Gough(Hudson Institute of Medical Research), Ricky W. Johnstone(Peter MacCallum Cancer Centre)
Cited by 196
Related Papers
New and emerging HDAC inhibitors for cancer treatment
|Journal of Clinical Investigation|2014|1.4k
BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
|Cell Reports|2017|297
T-cell acute leukaemia exhibits dynamic interactions with bone marrow microenvironments
|Nature|2016|205